BR112023020647A2 - Polipeptídeos, polipeptídeo recombinante ou sintético, molécula de ácido nucleico, vetor, célula hospedeira, usos de um polipeptídeo, processos para produzir ou expressar o polipeptídeo, conjugar duas moléculas ou componentes e purificar ou isolar uma molécula, aparelho e kits - Google Patents
Polipeptídeos, polipeptídeo recombinante ou sintético, molécula de ácido nucleico, vetor, célula hospedeira, usos de um polipeptídeo, processos para produzir ou expressar o polipeptídeo, conjugar duas moléculas ou componentes e purificar ou isolar uma molécula, aparelho e kitsInfo
- Publication number
- BR112023020647A2 BR112023020647A2 BR112023020647A BR112023020647A BR112023020647A2 BR 112023020647 A2 BR112023020647 A2 BR 112023020647A2 BR 112023020647 A BR112023020647 A BR 112023020647A BR 112023020647 A BR112023020647 A BR 112023020647A BR 112023020647 A2 BR112023020647 A2 BR 112023020647A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- nucleic acid
- molecule
- polypeptides
- producing
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 16
- 229920001184 polypeptide Polymers 0.000 title abstract 14
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 14
- 102000039446 nucleic acids Human genes 0.000 title abstract 6
- 108020004707 nucleic acids Proteins 0.000 title abstract 6
- 150000007523 nucleic acids Chemical class 0.000 title abstract 6
- 239000013598 vector Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 230000001268 conjugating effect Effects 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104999.4A GB202104999D0 (en) | 2021-04-08 | 2021-04-08 | Polypeptides that interact with peptide tags at loops or termini and uses thereof |
| PCT/GB2022/050841 WO2022214795A1 (en) | 2021-04-08 | 2022-04-01 | Polypeptides that interact with peptide tags at loops or termini and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023020647A2 true BR112023020647A2 (pt) | 2023-12-05 |
Family
ID=75949566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023020647A BR112023020647A2 (pt) | 2021-04-08 | 2022-04-01 | Polipeptídeos, polipeptídeo recombinante ou sintético, molécula de ácido nucleico, vetor, célula hospedeira, usos de um polipeptídeo, processos para produzir ou expressar o polipeptídeo, conjugar duas moléculas ou componentes e purificar ou isolar uma molécula, aparelho e kits |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240182530A1 (https=) |
| EP (1) | EP4320140A1 (https=) |
| JP (1) | JP2024513126A (https=) |
| KR (1) | KR20230165919A (https=) |
| CN (1) | CN117062828A (https=) |
| AU (1) | AU2022254857A1 (https=) |
| BR (1) | BR112023020647A2 (https=) |
| CA (1) | CA3214614A1 (https=) |
| GB (1) | GB202104999D0 (https=) |
| WO (1) | WO2022214795A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202313175D0 (en) | 2023-08-30 | 2023-10-11 | Univ Oxford Innovation Ltd | A bivalent polypeptide scaffold and uses thereof |
| GB202315107D0 (en) | 2023-10-02 | 2023-11-15 | Univ Oxford Innovation Ltd | Polypeptides and peptide tags capable of spontaneous isopeptide bond formation at low temperature and low pH and uses thereof |
| GB202317925D0 (en) | 2023-11-23 | 2024-01-10 | Spybiotech Ltd | Vaccines |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU530410B2 (en) | 1978-02-21 | 1983-07-14 | Sintef | Preparing aqueous emulsions |
| GB201002362D0 (en) | 2010-02-11 | 2010-03-31 | Isis Innovation | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| GB201509782D0 (en) * | 2015-06-05 | 2015-07-22 | Isis Innovation | Methods and products for fusion protein synthesis |
| GB201705750D0 (en) | 2017-04-10 | 2017-05-24 | Univ Oxford Innovation Ltd | Peptide ligase and use therof |
| GB201706430D0 (en) | 2017-04-24 | 2017-06-07 | Univ Oxford Innovation Ltd | Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof |
| GB201819850D0 (en) | 2018-12-05 | 2019-01-23 | Univ Oxford Innovation Ltd | Polypeptide and its use in affinity purification |
| GB201903479D0 (en) | 2019-03-14 | 2019-05-01 | Univ Oxford Innovation Ltd | Polypeptide with enchanced rate of spontaneous isopeptide bond formation with it's peptide tag partner and uses thereof |
-
2021
- 2021-04-08 GB GBGB2104999.4A patent/GB202104999D0/en not_active Ceased
-
2022
- 2022-04-01 CA CA3214614A patent/CA3214614A1/en active Pending
- 2022-04-01 CN CN202280024145.8A patent/CN117062828A/zh active Pending
- 2022-04-01 BR BR112023020647A patent/BR112023020647A2/pt unknown
- 2022-04-01 EP EP22716454.8A patent/EP4320140A1/en active Pending
- 2022-04-01 WO PCT/GB2022/050841 patent/WO2022214795A1/en not_active Ceased
- 2022-04-01 US US18/282,580 patent/US20240182530A1/en active Pending
- 2022-04-01 KR KR1020237038642A patent/KR20230165919A/ko active Pending
- 2022-04-01 AU AU2022254857A patent/AU2022254857A1/en active Pending
- 2022-04-01 JP JP2023561866A patent/JP2024513126A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024513126A (ja) | 2024-03-21 |
| AU2022254857A1 (en) | 2023-11-23 |
| WO2022214795A1 (en) | 2022-10-13 |
| KR20230165919A (ko) | 2023-12-05 |
| US20240182530A1 (en) | 2024-06-06 |
| CN117062828A (zh) | 2023-11-14 |
| CA3214614A1 (en) | 2022-10-13 |
| EP4320140A1 (en) | 2024-02-14 |
| GB202104999D0 (en) | 2021-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023020647A2 (pt) | Polipeptídeos, polipeptídeo recombinante ou sintético, molécula de ácido nucleico, vetor, célula hospedeira, usos de um polipeptídeo, processos para produzir ou expressar o polipeptídeo, conjugar duas moléculas ou componentes e purificar ou isolar uma molécula, aparelho e kits | |
| PE20191033A1 (es) | PROTEINAS DE FUSION FC HETERODIMERICAS IL 15/IL 15R(alfa) | |
| MX2025005685A (es) | Anticuerpos activables y metodos para elaborarlos y usarlos | |
| BR112018000477A2 (pt) | proteína de ligação de imunoglobulina não natural, composição, uso da proteína de ligação de ig não natural, método de purificação de afinidade de imunoglobulinas, método de geração de uma proteína de ligação de imunoglobulina não natural, molécula de ácido nucleico, vetor, célula hospedeira ou um hospedeiro não humano, e método para a produção de uma proteína de ligação de imunoglobulina não natural | |
| BR112021025130A2 (pt) | Reagentes e métodos para replicação, transcrição e tradução em organismos semissintéticos | |
| BR112021018734A2 (pt) | Receptores de células t e métodos de uso destes | |
| BR112012011740A2 (pt) | polipeptídeo, composição compreendendo o referido polipeptídeo, complexo de proteína, seqüência de nucleotídeo, vetor de expressão célula, e métodos para a preparação do complexo de proteína, para a preparação de um fviii, e para intensificar uma propriedade farmacocinética no plasma de um fviii | |
| CO6382161A2 (es) | Moleculas biespecificas de union a egfr/igfir | |
| MX353382B (es) | Moleculas de union polipeptido de larga duracion. | |
| AR071874A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| BR112016014810A2 (pt) | Antagonistas de fcrn e métodos de uso | |
| AR080229A1 (es) | Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23) | |
| MX2022013416A (es) | Polipeptidos de fusion para la produccion de peptidos objetivo. | |
| BR112018003594A2 (pt) | cadeia pesada de imunoglobulina recombinante, anticorpos, método de produção de conjugado e conjugados | |
| BR112021017464A2 (pt) | Receptores de células t e métodos de uso dos mesmos | |
| BR112021023218A2 (pt) | Polipeptídeos sintase de canabinoide otimizados | |
| JP2021522179A (ja) | タンパク質のマクロ環化 | |
| PH12023550779A1 (en) | Anti-sclerostin constructs and uses thereof | |
| BR112021017491A2 (pt) | Receptores de células t e métodos de uso dos mesmos | |
| Peng et al. | Probing the structure of human protein disulfide isomerase by chemical cross-linking combined with mass spectrometry | |
| CO2025009551A2 (es) | Receptores olfativos modificados | |
| MX2021001943A (es) | Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos. | |
| EA202091713A1 (ru) | Биологический синтез аминокислотных цепей для получения пептидов и белков | |
| BR112021026484A2 (pt) | Polimerização de enzimas para reações de sequenciamento | |
| BR112022001697A2 (pt) | Receptores de células t e métodos de uso dos mesmos |